• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供者 T 细胞中半乳糖凝集素-3 的表达可降低异基因造血细胞移植后移植物抗宿主病的严重程度和致死率。

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.

机构信息

Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

出版信息

Cell Rep. 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15.

DOI:10.1016/j.celrep.2023.112250
PMID:36924493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10116561/
Abstract

Abundant donor cytotoxic T cells that attack normal host organs remain a major problem for patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Despite an increase in our knowledge of the pathobiology of acute graft versus host disease (aGvHD), the mechanisms regulating the proliferation and function of donor T cells remain unclear. Here, we show that activated donor T cells express galectin-3 (Gal-3) after allo-HCT. In both major and minor histocompatibility-mismatched models of murine aGvHD, expression of Gal-3 is associated with decreased T cell activation and suppression of the secretion of effector cytokines, including IFN-γ and GM-CSF. Mechanistically, Gal-3 results in activation of NFAT signaling, which can induce T cell exhaustion. Gal-3 overexpression in human T cells prevents severe disease by suppressing cytotoxic T cells in xenogeneic aGvHD models. Together, these data identify the Gal-3-dependent regulatory pathway in donor T cells as a critical component of inflammation in aGvHD.

摘要

在接受异基因造血细胞移植(allo-HCT)的患者中,攻击正常宿主器官的大量供体细胞毒性 T 细胞仍然是一个主要问题。尽管我们对急性移植物抗宿主病(aGvHD)的病理生物学有了更多的了解,但调节供体 T 细胞增殖和功能的机制仍不清楚。在这里,我们表明,激活的供体 T 细胞在 allo-HCT 后表达半乳糖凝集素-3(Gal-3)。在小鼠 aGvHD 的主要和次要组织相容性不匹配模型中,Gal-3 的表达与 T 细胞活化减少和效应细胞因子(包括 IFN-γ 和 GM-CSF)分泌的抑制有关。从机制上讲,Gal-3 导致 NFAT 信号的激活,从而诱导 T 细胞耗竭。Gal-3 在人 T 细胞中的过表达通过抑制异种移植物抗宿主病模型中的细胞毒性 T 细胞来预防严重疾病。总之,这些数据确定了供体 T 细胞中 Gal-3 依赖性调节途径是 aGvHD 炎症的一个关键组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/78396005ee58/nihms-1887307-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/76991a4462c8/nihms-1887307-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/4300b7c23866/nihms-1887307-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/e4155ce2f71a/nihms-1887307-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/a60f280eab6b/nihms-1887307-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/3b6b7caeb076/nihms-1887307-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/78396005ee58/nihms-1887307-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/76991a4462c8/nihms-1887307-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/4300b7c23866/nihms-1887307-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/e4155ce2f71a/nihms-1887307-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/a60f280eab6b/nihms-1887307-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/3b6b7caeb076/nihms-1887307-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce9/10116561/78396005ee58/nihms-1887307-f0007.jpg

相似文献

1
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.供者 T 细胞中半乳糖凝集素-3 的表达可降低异基因造血细胞移植后移植物抗宿主病的严重程度和致死率。
Cell Rep. 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15.
2
Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.Galectin-9 表达增加是移植物抗宿主病(aGVHD)的预后生物标志物,在异基因造血干细胞移植后,通过 Galectin-9 诱导的髓系来源抑制细胞(MDSC)通路调节免疫反应。
Int Immunopharmacol. 2020 Nov;88:106929. doi: 10.1016/j.intimp.2020.106929. Epub 2020 Sep 1.
3
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.供者自然杀伤细胞对同种反应性 T 细胞的细胞毒性与异基因造血干细胞移植后急性移植物抗宿主病有关。
Front Immunol. 2020 Jul 31;11:1534. doi: 10.3389/fimmu.2020.01534. eCollection 2020.
4
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.T 细胞表面标志物面板预测小鼠急性移植物抗宿主病。
Front Immunol. 2021 Jan 29;11:593321. doi: 10.3389/fimmu.2020.593321. eCollection 2020.
5
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.STING 通过限制抗原呈递细胞的功能来负调控同种异体 T 细胞反应。
Cell Mol Immunol. 2021 Mar;18(3):632-643. doi: 10.1038/s41423-020-00611-6. Epub 2021 Jan 26.
6
β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD.供体细胞上的β2-肾上腺素能受体的激活可改善急性移植物抗宿主病。
JCI Insight. 2020 Jun 18;5(12):137788. doi: 10.1172/jci.insight.137788.
7
Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.同种异体 T 细胞在造血细胞移植后会引起急性肾损伤。
Blood Adv. 2023 Nov 28;7(22):6936-6948. doi: 10.1182/bloodadvances.2023009721.
8
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
9
Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.半相合造血干细胞移植后半乳糖凝集素-9 通过调节调节性 T 细胞/效应 T 细胞失衡缓解急性移植物抗宿主病。
Immun Inflamm Dis. 2024 Feb;12(2):e1177. doi: 10.1002/iid3.1177.
10
Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.线粒体去乙酰化酶 SIRT3 在实验性同种异体造血移植后供体细胞反应中发挥重要作用。
J Immunol. 2018 Dec 1;201(11):3443-3455. doi: 10.4049/jimmunol.1800148. Epub 2018 Nov 2.

引用本文的文献

1
Intracellular galectin interactions in health and disease.细胞内半乳糖凝集素相互作用与健康和疾病。
Semin Immunopathol. 2024 Jul 11;46(1-2):4. doi: 10.1007/s00281-024-01010-z.
2
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.半乳糖凝集素-3 可预测减低强度异基因造血干细胞移植后急性移植物抗宿主病和总死亡率:一项 BMT-CTN 生物库研究。
Bone Marrow Transplant. 2024 Mar;59(3):334-343. doi: 10.1038/s41409-023-02168-0. Epub 2023 Dec 18.
3
Galectin-3 promotes brain injury by modulating the phenotype of microglia via binding TLR-4 after intracerebral hemorrhage.

本文引用的文献

1
The Pathophysiology and Treatment of Graft--Host Disease: Lessons Learnt From Animal Models.移植物抗宿主病的病理生理学与治疗:从动物模型中获得的经验教训
Front Immunol. 2021 Aug 19;12:715424. doi: 10.3389/fimmu.2021.715424. eCollection 2021.
2
Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.细胞毒性 T 淋巴细胞相关抗原-4 通过调节人 T 细胞嵌合体和基因表达改变诱导的宿主免疫反应,调节小鼠异种移植物抗宿主病的发展。
Clin Exp Immunol. 2021 Dec;206(3):422-438. doi: 10.1111/cei.13659. Epub 2021 Sep 22.
3
半乳糖凝集素-3 通过与脑内出血后 TLR-4 结合来调节小胶质细胞的表型,从而促进脑损伤。
Aging (Albany NY). 2023 Sep 11;15(17):9041-9058. doi: 10.18632/aging.205014.
Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease.
长期驻留皮肤的记忆T细胞在原位增殖,并参与人类移植物抗宿主病。
Sci Transl Med. 2020 Nov 18;12(570). doi: 10.1126/scitranslmed.abb7028.
4
T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect.T细胞耗竭和抗原呈递功能障碍导致对移植物抗白血病效应产生抗性。
Nat Commun. 2020 Aug 24;11(1):4227. doi: 10.1038/s41467-020-17991-y.
5
β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD.供体细胞上的β2-肾上腺素能受体的激活可改善急性移植物抗宿主病。
JCI Insight. 2020 Jun 18;5(12):137788. doi: 10.1172/jci.insight.137788.
6
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD.剖析异基因 HSCT 的生物学特性,在最大限度降低 GvHD 的同时增强 GvT 效应。
Nat Rev Clin Oncol. 2020 Aug;17(8):475-492. doi: 10.1038/s41571-020-0356-4. Epub 2020 Apr 20.
7
CD29 identifies IFN-γ-producing human CD8 T cells with an increased cytotoxic potential.CD29 可鉴定具有增强细胞毒性潜力的 IFN-γ 产生的人 CD8 T 细胞。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6686-6696. doi: 10.1073/pnas.1913940117. Epub 2020 Mar 11.
8
A new role for an old cytokine: GM-CSF amplifies GVHD.一种旧细胞因子的新作用:GM-CSF 扩增 GVHD。
Blood. 2020 Feb 20;135(8):520-521. doi: 10.1182/blood.2019004681.
9
Systemic β-Adrenergic Receptor Activation Augments the Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells.系统β-肾上腺素能受体激活增强了 Vγ9Vδ2 T 细胞的扩增和抗肿瘤活性。
Front Immunol. 2020 Jan 24;10:3082. doi: 10.3389/fimmu.2019.03082. eCollection 2019.
10
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.致病的 Bhlhe40+ GM-CSF+ CD4+ T 细胞在移植物抗宿主病期间促进胃肠道中的间接同种抗原呈递。
Blood. 2020 Feb 20;135(8):568-581. doi: 10.1182/blood.2019001696.